In bladder cancer cells, UCA1 regulates the glutamine metabolism and antioxidant defense by inhibiting miR-16, which targets GLS2 for translational inhibiting and reduced GLS2 expression. This evidence concerns the gene UCA1 and urinary bladder cancer.